Shanghai Allist Pharmaceuticals Co., Ltd.

Shanghai Stock Exchange 688578.SS

Shanghai Allist Pharmaceuticals Co., Ltd. Total Assets for the year ending December 31, 2023: USD 616.43 M

Shanghai Allist Pharmaceuticals Co., Ltd. Total Assets is USD 616.43 M for the year ending December 31, 2023, a 23.58% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
  • Shanghai Allist Pharmaceuticals Co., Ltd. Total Assets for the year ending December 31, 2022 was USD 498.81 M, a 1.25% change year over year.
  • Shanghai Allist Pharmaceuticals Co., Ltd. Total Assets for the year ending December 31, 2021 was USD 492.64 M, a 7.65% change year over year.
  • Shanghai Allist Pharmaceuticals Co., Ltd. Total Assets for the year ending December 31, 2020 was USD 457.62 M, a 139.89% change year over year.
  • Shanghai Allist Pharmaceuticals Co., Ltd. Total Assets for the year ending December 31, 2019 was USD 190.76 M, a 249.86% change year over year.
Key data
Date Total Assets Current Liabilities Total Non-Current Liabilities Shareholders' Equity
Market news
SV Wall Street
Shanghai Stock Exchange: 688578.SS

Shanghai Allist Pharmaceuticals Co., Ltd.

CEO Mr. Jinhao Du
IPO Date Dec. 2, 2020
Location China
Headquarters No. 268 Lingxiaohua Road
Employees 1,044
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Clinical Trials
Description

Shanghai Allist Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in China. It offers pharmaceuticals for the treatment of tumor and cancer diseases. The company was founded in 2004 and is based in Shanghai, China.

StockViz Staff

February 2, 2025

Any question? Send us an email